Amgen stock rises on cancer drug news
5th Nov 2005, 00:15 GMT
Amgen's stock price climbed for a second consecutive day after the biotech and its partner Abgenix unveiled new data for an anti-cancer antibody.
Amgen stock rises on cancer drug news related news:
- Abgenix-Amgen cancer drug gets favorable test result — SacBee -- Business
- Abgenix, Amgen stock up on successful cancer treatment test — bizjournals.com Health Care:Pharmaceuticals headlines
- Experimental cancer drug results sends biotech companies' stocks soaring — SacBee -- Business
- Amgen boosts drug stocks 2nd day — Bio-Technology News from StratCenter.com
- Abgenix, Amgen cancer treatment test successful — bizjournals.com Health Care:Pharmaceuticals headlines
- Colon-cancer drug success — RSS Top Stories -- SiliconValley.com
- United States drug manufacturer Amgen Inc has defended its decision ... — Top Stories Photos - AFP on Yahoo! News Photos
- Amgen, Abgenix Shares Rise on Trial News — WTOP Radio - Business News
- Amgen's Cancer-Drug Staves Off Disease — TechNewsWorld
- Sponsorship of top cycling races has taken a new twist with ... — Sports Photos - AFP on Yahoo! News Photos
Latest news from CNN/Money:
- Why Democrats love technology
- PR mega-flack tries newspaper rescue
- Merck: New pain killer safer than Vioxx
- Cisco snaps up networking company
- Ford layoffs humming along
- Oil drops as rally loses gas
- A startup crushes its copycats
- Hitachi, GE expand nuclear alliance
- Hot stocks: Clear Channel, Ford, IBM, more
- IBM joins in $3 billion bid for Chinese bank